Symbol:
Ccr5
Name:
C-C motif chemokine receptor 5
RGD ID:
620596
Description:
Enables protein kinase binding activity. Involved in several processes, including negative regulation of axon extension; positive regulation of cytokine production; and response to bacterium. Located in cell surface and endosome. Used to study Alzheimer's disease and plague. Biomarker of several diseases, including artery disease (multiple); diabetes mellitus (multiple); end stage renal disease; orchitis; and uveitis (multiple). Human ortholog(s) of this gene implicated in several diseases, including Kawasaki disease; West Nile fever; autoimmune disease (multiple); berylliosis; and sarcoidosis (multiple). Orthologous to human CCR5 (C-C motif chemokine receptor 5); PARTICIPATES IN interleukin-12 signaling pathway; chemokine mediated signaling pathway; cytokine mediated signaling pathway; INTERACTS WITH 17alpha-ethynylestradiol; 17beta-estradiol; 17beta-estradiol 3-benzoate.
Type:
protein-coding
RefSeq Status:
VALIDATED
Previously known as:
C-C chemokine receptor type 5; C-C CKR-5; CC-CKR-5; CCR-5; chemokine (C-C motif) receptor 5; chemokine (C-C) receptor 5; Ckr5; Cmkbr5; MIP-1 alpha receptor
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 132,629,097 - 132,660,980 (+) NCBI GRCr8 mRatBN7.2 8 123,752,423 - 123,757,538 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 123,752,325 - 123,759,260 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 129,343,076 - 129,348,190 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 127,542,196 - 127,547,310 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 125,360,117 - 125,365,231 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 133,192,398 - 133,215,599 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 133,197,032 - 133,215,614 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 132,362,664 - 132,367,779 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 128,907,157 - 128,912,272 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 128,929,594 - 128,932,000 (+) NCBI Celera 8 122,847,673 - 122,852,786 (+) NCBI Celera Cytogenetic Map 8 q32 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Ccr5 Rat (S)-nicotine increases expression ISO CCR5 (Homo sapiens) 6480464 Nicotine results in increased expression of CCR5 mRNA CTD PMID:18247414 Ccr5 Rat 1,3-benzothiazole-2-thiol increases expression ISO CCR5 (Homo sapiens) 6480464 captax results in increased expression of CCR5 mRNA CTD PMID:20713136 Ccr5 Rat 1-chloro-2,4-dinitrobenzene increases expression ISO CCR5 (Homo sapiens) 6480464 Dinitrochlorobenzene results in increased expression of CCR5 mRNA CTD PMID:20713136 Ccr5 Rat 17alpha-ethynylestradiol multiple interactions ISO CCR5 (Homo sapiens) 6480464 [Ethinyl Estradiol co-treated with Cyproterone Acetate] results in increased expression of CCR5 protein CTD PMID:10770211 Ccr5 Rat 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of CCR5 mRNA CTD PMID:15834898 Ccr5 Rat 17alpha-ethynylestradiol multiple interactions ISO Ccr5 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CCR5 mRNA CTD PMID:17942748 Ccr5 Rat 17alpha-ethynylestradiol increases expression ISO Ccr5 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CCR5 mRNA CTD PMID:17942748 Ccr5 Rat 17alpha-ethynylestradiol decreases expression ISO Ccr5 (Mus musculus) 6480464 Ethinyl Estradiol results in decreased expression of CCR5 mRNA CTD PMID:12538720 and PMID:15885639 Ccr5 Rat 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCR5 mRNA CTD PMID:32741896 Ccr5 Rat 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCR5 mRNA CTD PMID:32741896 Ccr5 Rat 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO Ccr5 (Mus musculus) 6480464 2 more ... CTD PMID:21851831 Ccr5 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Ccr5 (Mus musculus) 6480464 2 more ... CTD PMID:21851831 Ccr5 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Ccr5 (Mus musculus) 6480464 2 more ... CTD PMID:17942748 and PMID:21851831 Ccr5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of CCR5 mRNA CTD PMID:34747641 Ccr5 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CCR5 mRNA CTD PMID:32109520 Ccr5 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Ccr5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CCR5 mRNA CTD PMID:18684927 more ... Ccr5 Rat 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ccr5 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of CCR5 mRNA CTD PMID:21570461 Ccr5 Rat 2,4,6-trinitrobenzenesulfonic acid increases expression ISO Ccr5 (Mus musculus) 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CCR5 mRNA CTD PMID:15973123 and PMID:17982090 Ccr5 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Ccr5 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Ccr5 Rat 2-naphthylamine increases expression ISO CCR5 (Homo sapiens) 6480464 2-Naphthylamine results in increased expression of CCR5 mRNA CTD PMID:18247414 Ccr5 Rat 3-chlorophenol decreases expression ISO CCR5 (Homo sapiens) 6480464 3-chlorophenol results in decreased expression of CCR5 mRNA CTD PMID:18486366 Ccr5 Rat 4,4'-sulfonyldiphenol decreases expression ISO Ccr5 (Mus musculus) 6480464 bisphenol S results in decreased expression of CCR5 mRNA CTD PMID:39298647 Ccr5 Rat 4,4'-sulfonyldiphenol decreases methylation ISO CCR5 (Homo sapiens) 6480464 bisphenol S results in decreased methylation of CCR5 gene CTD PMID:31601247 Ccr5 Rat 4-amino-2,6-dinitrotoluene affects expression EXP 6480464 4-amino-2 and 6-dinitrotoluene affects the expression of CCR5 mRNA CTD PMID:21346803 Ccr5 Rat 4-hydroxyphenyl retinamide decreases expression ISO Ccr5 (Mus musculus) 6480464 Fenretinide results in decreased expression of CCR5 mRNA CTD PMID:28973697 Ccr5 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of CCR5 mRNA CTD PMID:31881176 Ccr5 Rat aflatoxin B1 increases expression ISO Ccr5 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of CCR5 mRNA CTD PMID:19770486 Ccr5 Rat aflatoxin B1 decreases expression EXP 6480464 Aflatoxin B1 results in decreased expression of CCR5 mRNA CTD PMID:33354967 Ccr5 Rat aflatoxin B1 increases methylation ISO CCR5 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of CCR5 gene CTD PMID:27153756 Ccr5 Rat ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CCR5 mRNA CTD PMID:16483693 Ccr5 Rat amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of CCR5 mRNA CTD PMID:30779732 Ccr5 Rat Ancriviroc multiple interactions ISO CCR5 (Homo sapiens) 6480464 Ancriviroc inhibits the reaction [CCL3 protein binds to CCR5 protein] CTD PMID:15644495 Ccr5 Rat antirheumatic drug decreases expression ISO CCR5 (Homo sapiens) 6480464 Antirheumatic Agents results in decreased expression of CCR5 mRNA CTD PMID:24449571 Ccr5 Rat arsane multiple interactions ISO Ccr5 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCR5 mRNA CTD PMID:30889423 Ccr5 Rat arsenic atom multiple interactions ISO Ccr5 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCR5 mRNA CTD PMID:30889423 Ccr5 Rat Azoxymethane multiple interactions ISO Ccr5 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR5 mRNA CTD PMID:29950665 Ccr5 Rat Bardoxolone methyl multiple interactions ISO CCR5 (Homo sapiens) 6480464 bardoxolone methyl promotes the reaction [Lipopolysaccharides results in increased expression of CCR5 mRNA] CTD PMID:26918785 Ccr5 Rat benzalkonium chloride increases expression ISO Ccr5 (Mus musculus) 6480464 Benzalkonium Compounds results in increased expression of CCR5 mRNA CTD PMID:30171875 Ccr5 Rat benzene increases expression ISO CCR5 (Homo sapiens) 6480464 Benzene results in increased expression of CCR5 mRNA CTD PMID:19162166 Ccr5 Rat benzo[a]pyrene increases expression ISO CCR5 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of CCR5 mRNA CTD PMID:18247414 Ccr5 Rat benzo[a]pyrene increases expression ISO Ccr5 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of CCR5 mRNA CTD PMID:30165701 Ccr5 Rat benzo[a]pyrene affects methylation ISO CCR5 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of CCR5 5' UTR CTD PMID:27901495 Ccr5 Rat benzo[a]pyrene multiple interactions ISO Ccr5 (Mus musculus) 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CCR5 mRNA] and Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CCR5 mRNA] CTD PMID:22228805 and PMID:30165701 Ccr5 Rat benzo[a]pyrene decreases expression ISO Ccr5 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CCR5 mRNA CTD PMID:21569818 Ccr5 Rat bis(2-chloroethyl) sulfide increases expression ISO Ccr5 (Mus musculus) 6480464 Mustard Gas results in increased expression of CCR5 mRNA CTD PMID:18955075 Ccr5 Rat bis(2-ethylhexyl) phthalate multiple interactions ISO Ccr5 (Mus musculus) 6480464 Diethylhexyl Phthalate promotes the reaction [Dietary Fats results in increased expression of CCR5 mRNA] CTD PMID:34303773 Ccr5 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CCR5 mRNA CTD PMID:25181051 Ccr5 Rat bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CCR5 mRNA CTD PMID:30816183 and PMID:32528016 Ccr5 Rat bisphenol F increases expression ISO Ccr5 (Mus musculus) 6480464 bisphenol F results in increased expression of CCR5 mRNA CTD PMID:30951980 and PMID:38685157 Ccr5 Rat bleomycin A2 affects expression ISO Ccr5 (Mus musculus) 6480464 Bleomycin affects the expression of CCR5 mRNA CTD PMID:26345256 Ccr5 Rat bleomycin A2 multiple interactions ISO Ccr5 (Mus musculus) 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of CCR5 mRNA] and lenabasum inhibits the reaction [Bleomycin results in increased expression of CCR5 mRNA] CTD PMID:30825431 Ccr5 Rat bleomycin A2 increases expression ISO Ccr5 (Mus musculus) 6480464 Bleomycin results in increased expression of CCR5 mRNA CTD PMID:30825431 Ccr5 Rat buta-1,3-diene decreases expression ISO Ccr5 (Mus musculus) 6480464 1 and 3-butadiene results in decreased expression of CCR5 mRNA CTD PMID:29038090 Ccr5 Rat cadmium atom multiple interactions ISO Ccr5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCR5 mRNA CTD PMID:36200916 Ccr5 Rat cadmium dichloride multiple interactions ISO Ccr5 (Mus musculus) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in increased expression of CCR5 mRNA CTD PMID:36200916 Ccr5 Rat cannabidiol multiple interactions ISO Ccr5 (Mus musculus) 6480464 Cannabidiol analog inhibits the reaction [Bleomycin results in increased expression of CCR5 mRNA] CTD PMID:30825431 Ccr5 Rat carbon nanotube increases expression ISO Ccr5 (Mus musculus) 6480464 Nanotubes more ... CTD PMID:25554681 and PMID:25620056 Ccr5 Rat carbon nanotube affects response to substance ISO Ccr5 (Mus musculus) 6480464 CCR5 gene mutant form affects the susceptibility to Nanotubes and Carbon CTD PMID:22438032 Ccr5 Rat celecoxib decreases expression ISO Ccr5 (Mus musculus) 6480464 Celecoxib results in decreased expression of CCR5 mRNA CTD PMID:12902868 Ccr5 Rat CGP 52608 multiple interactions ISO CCR5 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to CCR5 gene] CTD PMID:28238834 Ccr5 Rat chloroprene decreases expression ISO Ccr5 (Mus musculus) 6480464 Chloroprene results in decreased expression of CCR5 mRNA CTD PMID:23125180 Ccr5 Rat Cirsimarin decreases expression ISO CCR5 (Homo sapiens) 6480464 cirsimarin results in decreased expression of CCR5 mRNA CTD PMID:35710092 Ccr5 Rat cisplatin increases expression ISO Ccr5 (Mus musculus) 6480464 Cisplatin results in increased expression of CCR5 mRNA CTD PMID:15814532 Ccr5 Rat cisplatin multiple interactions ISO Ccr5 (Mus musculus) 6480464 pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCR5 mRNA] CTD PMID:15814532 Ccr5 Rat clofibrate increases expression ISO Ccr5 (Mus musculus) 6480464 Clofibrate results in increased expression of CCR5 mRNA CTD PMID:17585979 Ccr5 Rat cocaine increases expression ISO CCR5 (Homo sapiens) 6480464 Cocaine results in increased expression of CCR5 protein CTD PMID:16204638 Ccr5 Rat crocidolite asbestos increases expression ISO Ccr5 (Mus musculus) 6480464 Asbestos and Crocidolite results in increased expression of CCR5 mRNA CTD PMID:29279043 and PMID:29507420 Ccr5 Rat Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CCR5 mRNA CTD PMID:27523638 Ccr5 Rat cyclophosphamide increases expression ISO Ccr5 (Mus musculus) 6480464 Cyclophosphamide results in increased expression of CCR5 mRNA CTD PMID:15331540 Ccr5 Rat cyclosporin A increases expression ISO Ccr5 (Mus musculus) 6480464 Cyclosporine results in increased expression of CCR5 protein CTD PMID:21292993 Ccr5 Rat cyproterone acetate multiple interactions ISO CCR5 (Homo sapiens) 6480464 [Ethinyl Estradiol co-treated with Cyproterone Acetate] results in increased expression of CCR5 protein CTD PMID:10770211 Ccr5 Rat D-penicillamine increases expression EXP 6480464 Penicillamine results in increased expression of CCR5 mRNA CTD PMID:19575532 Ccr5 Rat D-penicillamine decreases expression EXP 6480464 Penicillamine results in decreased expression of CCR5 mRNA CTD PMID:19575532 Ccr5 Rat dextran sulfate multiple interactions ISO Ccr5 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR5 mRNA CTD PMID:29950665 Ccr5 Rat Dibutyl phosphate affects expression ISO CCR5 (Homo sapiens) 6480464 di-n-butylphosphoric acid affects the expression of CCR5 mRNA CTD PMID:37042841 Ccr5 Rat diclofenac increases expression ISO Ccr5 (Mus musculus) 6480464 Diclofenac results in increased expression of CCR5 mRNA CTD PMID:26934552 Ccr5 Rat Didecyldimethylammonium increases expression ISO Ccr5 (Mus musculus) 6480464 didecyldimethylammonium results in increased expression of CCR5 mRNA CTD PMID:19762220 Ccr5 Rat dioxygen increases expression ISO Ccr5 (Mus musculus) 6480464 Oxygen deficiency results in increased expression of CCR5 mRNA and Oxygen deficiency results in increased expression of CCR5 protein CTD PMID:20880076 Ccr5 Rat dioxygen multiple interactions ISO Ccr5 (Mus musculus) 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CCR5 mRNA and HIF1A protein promotes the reaction [Oxygen deficiency results in increased expression of CCR5 mRNA] CTD PMID:20880076 and PMID:30529165 Ccr5 Rat disulfiram multiple interactions ISO Ccr5 (Mus musculus) 6480464 Disulfiram inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] more ... CTD PMID:19016906 Ccr5 Rat diuron decreases expression ISO CCR5 (Homo sapiens) 6480464 Diuron results in decreased expression of CCR5 mRNA CTD PMID:35967413 Ccr5 Rat enniatin decreases expression ISO CCR5 (Homo sapiens) 6480464 enniatins results in decreased expression of CCR5 mRNA CTD PMID:36016515 Ccr5 Rat ethyl methanesulfonate decreases expression ISO CCR5 (Homo sapiens) 6480464 Ethyl Methanesulfonate results in decreased expression of CCR5 mRNA CTD PMID:23649840 Ccr5 Rat eugenol increases expression ISO CCR5 (Homo sapiens) 6480464 Eugenol results in increased expression of CCR5 mRNA CTD PMID:17936526 and PMID:20713136 Ccr5 Rat formaldehyde decreases expression ISO CCR5 (Homo sapiens) 6480464 Formaldehyde results in decreased expression of CCR5 mRNA CTD PMID:23649840 Ccr5 Rat graphene oxide increases expression ISO Ccr5 (Mus musculus) 6480464 graphene oxide results in increased expression of CCR5 mRNA CTD PMID:33227293 Ccr5 Rat indole-3-methanol increases expression ISO CCR5 (Homo sapiens) 6480464 indole-3-carbinol results in increased expression of CCR5 protein CTD PMID:27783115 Ccr5 Rat isopentenyl diphosphate decreases expression ISO CCR5 (Homo sapiens) 6480464 isopentenyl pyrophosphate results in decreased expression of CCR5 protein CTD PMID:11994442 Ccr5 Rat ketamine increases expression EXP 6480464 Ketamine results in increased expression of CCR5 mRNA CTD PMID:20080153 Ccr5 Rat lipopolysaccharide multiple interactions ISO CCR5 (Homo sapiens) 6480464 bardoxolone methyl promotes the reaction [Lipopolysaccharides results in increased expression of CCR5 mRNA] CTD PMID:26918785 Ccr5 Rat lipopolysaccharide increases response to substance ISO Ccr5 (Mus musculus) 6480464 CCR5 gene mutant form results in increased susceptibility to Lipopolysaccharides CTD PMID:26055553 Ccr5 Rat lipopolysaccharide multiple interactions ISO Ccr5 (Mus musculus) 6480464 [CCR5 gene mutant form results in increased susceptibility to Lipopolysaccharides] which results in increased cleavage of CASP3 protein more ... CTD PMID:26055553 Ccr5 Rat lipopolysaccharide increases expression ISO CCR5 (Homo sapiens) 6480464 Lipopolysaccharides results in increased expression of CCR5 mRNA CTD PMID:26918785 Ccr5 Rat maraviroc multiple interactions ISO CCR5 (Homo sapiens) 6480464 maraviroc binds to and results in decreased activity of CCR5 protein more ... CTD PMID:15644495 and PMID:21128663 Ccr5 Rat mechlorethamine increases expression EXP 6480464 Mechlorethamine results in increased expression of CCR5 mRNA CTD PMID:26273949 Ccr5 Rat mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of CCR5 mRNA and Mercuric Chloride results in increased expression of CCR5 protein CTD PMID:12834626 Ccr5 Rat mercury dichloride increases response to substance EXP 6480464 CCR5 protein results in increased susceptibility to Mercuric Chloride CTD PMID:12834626 Ccr5 Rat methamphetamine decreases expression EXP 6480464 Methamphetamine results in decreased expression of CCR5 mRNA CTD PMID:19564919 Ccr5 Rat methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of CCR5 mRNA CTD PMID:19564919 Ccr5 Rat methyl methanesulfonate decreases expression ISO CCR5 (Homo sapiens) 6480464 Methyl Methanesulfonate results in decreased expression of CCR5 mRNA CTD PMID:23649840 Ccr5 Rat mevalonic acid multiple interactions ISO CCR5 (Homo sapiens) 6480464 Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCR5 mRNA]] CTD PMID:16321392 Ccr5 Rat microcystin-LR increases expression ISO Ccr5 (Mus musculus) 6480464 cyanoginosin LR results in increased expression of CCR5 mRNA CTD PMID:37342990 Ccr5 Rat mycotoxin increases expression ISO Ccr5 (Mus musculus) 6480464 Mycotoxins results in increased expression of CCR5 mRNA CTD PMID:19818335 Ccr5 Rat mycotoxin decreases expression ISO Ccr5 (Mus musculus) 6480464 Mycotoxins results in decreased expression of CCR5 mRNA CTD PMID:19818335 Ccr5 Rat nickel atom affects expression ISO CCR5 (Homo sapiens) 6480464 Nickel affects the expression of CCR5 mRNA CTD PMID:14575637 Ccr5 Rat nickel atom increases expression ISO CCR5 (Homo sapiens) 6480464 Nickel results in increased expression of CCR5 mRNA CTD PMID:25583101 Ccr5 Rat nickel atom multiple interactions ISO CCR5 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of CCR5 mRNA] CTD PMID:14575637 Ccr5 Rat nicotine increases expression ISO CCR5 (Homo sapiens) 6480464 Nicotine results in increased expression of CCR5 mRNA CTD PMID:18247414 Ccr5 Rat nitric oxide multiple interactions ISO Ccr5 (Mus musculus) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] more ... CTD PMID:19016906 Ccr5 Rat oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CCR5 mRNA CTD PMID:25729387 Ccr5 Rat paracetamol increases response to substance ISO Ccr5 (Mus musculus) 6480464 CCR5 protein results in increased susceptibility to Acetaminophen CTD PMID:24770590 Ccr5 Rat pentachlorophenol decreases expression ISO CCR5 (Homo sapiens) 6480464 Pentachlorophenol results in decreased expression of CCR5 mRNA CTD PMID:18486366 Ccr5 Rat phenobarbital affects expression ISO Ccr5 (Mus musculus) 6480464 Phenobarbital affects the expression of CCR5 mRNA CTD PMID:23091169 Ccr5 Rat pirinixic acid multiple interactions ISO Ccr5 (Mus musculus) 6480464 pirinixic acid inhibits the reaction [Cisplatin results in increased expression of CCR5 mRNA] CTD PMID:15814532 Ccr5 Rat proanthocyanidin decreases expression ISO CCR5 (Homo sapiens) 6480464 proanthocyanidin results in decreased expression of CCR5 mRNA CTD PMID:12462994 Ccr5 Rat prostaglandin E2 decreases expression ISO CCR5 (Homo sapiens) 6480464 Dinoprostone results in decreased expression of CCR5 mRNA and Dinoprostone results in decreased expression of CCR5 protein CTD PMID:16303787 Ccr5 Rat protein kinase inhibitor multiple interactions ISO CCR5 (Homo sapiens) 6480464 Protein Kinase Inhibitors inhibits the reaction [gardiquimod results in increased expression of CCR5 mRNA] CTD PMID:28003376 Ccr5 Rat reactive oxygen species multiple interactions ISO Ccr5 (Mus musculus) 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Reactive Oxygen Species] more ... CTD PMID:19016906 Ccr5 Rat resveratrol multiple interactions ISO Ccr5 (Mus musculus) 6480464 Resveratrol inhibits the reaction [Benzo(a)pyrene results in increased expression of CCR5 mRNA] CTD PMID:30165701 Ccr5 Rat SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in decreased expression of CCR5 mRNA CTD PMID:19564919 Ccr5 Rat sevoflurane decreases methylation ISO Ccr5 (Mus musculus) 6480464 Sevoflurane results in decreased methylation of CCR5 mRNA CTD PMID:35249202 Ccr5 Rat silicon dioxide increases expression ISO Ccr5 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of CCR5 mRNA CTD PMID:29341224 Ccr5 Rat simvastatin multiple interactions ISO CCR5 (Homo sapiens) 6480464 Mevalonic Acid inhibits the reaction [Simvastatin inhibits the reaction [IFNG results in increased expression of CCR5 mRNA]] and Simvastatin inhibits the reaction [IFNG results in increased expression of CCR5 mRNA] CTD PMID:16321392 Ccr5 Rat simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of CCR5 protein CTD PMID:17449418 Ccr5 Rat simvastatin decreases expression ISO CCR5 (Homo sapiens) 6480464 Simvastatin results in decreased expression of CCR5 mRNA CTD PMID:17112859 Ccr5 Rat sodium arsenite multiple interactions ISO Ccr5 (Mus musculus) 6480464 [sodium arsenite results in increased abundance of Arsenic] which results in increased expression of CCR5 mRNA CTD PMID:30889423 Ccr5 Rat sodium dodecyl sulfate decreases expression ISO CCR5 (Homo sapiens) 6480464 Sodium Dodecyl Sulfate results in decreased expression of CCR5 mRNA CTD PMID:17936526 Ccr5 Rat Soman increases expression EXP 6480464 Soman results in increased expression of CCR5 mRNA CTD PMID:19281266 Ccr5 Rat staurosporine multiple interactions EXP 6480464 Staurosporine inhibits the reaction [[CXCL8 protein binds to and results in increased activity of CXCR1 protein] which results in increased phosphorylation of and affects the localization of CCR5 protein] CTD PMID:12594210 Ccr5 Rat testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of CCR5 mRNA CTD PMID:32741896 Ccr5 Rat tetrachloromethane multiple interactions ISO Ccr5 (Mus musculus) 6480464 PPARD protein affects the reaction [Carbon Tetrachloride results in increased expression of CCR5 mRNA] CTD PMID:18038451 Ccr5 Rat tetrachloromethane increases expression ISO Ccr5 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CCR5 mRNA CTD PMID:23288052 Ccr5 Rat titanium dioxide increases expression ISO Ccr5 (Mus musculus) 6480464 titanium dioxide results in increased expression of CCR5 mRNA CTD PMID:21259345 more ... Ccr5 Rat titanium dioxide multiple interactions ISO Ccr5 (Mus musculus) 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CCR5 mRNA CTD PMID:29950665 Ccr5 Rat TMC-120A decreases expression ISO Ccr5 (Mus musculus) 6480464 TMC 120A results in decreased expression of CCR5 mRNA CTD PMID:19818335 Ccr5 Rat TMC-120A increases expression ISO Ccr5 (Mus musculus) 6480464 TMC 120A results in increased expression of CCR5 mRNA CTD PMID:19818335 Ccr5 Rat topotecan increases expression EXP 6480464 Topotecan results in increased expression of CCR5 mRNA CTD PMID:25729387 Ccr5 Rat tremolite asbestos increases expression ISO Ccr5 (Mus musculus) 6480464 tremolite results in increased expression of CCR5 mRNA CTD PMID:29279043 Ccr5 Rat trichostatin A multiple interactions ISO CCR5 (Homo sapiens) 6480464 trichostatin A inhibits the reaction [Nickel affects the expression of CCR5 mRNA] CTD PMID:14575637 Ccr5 Rat trimellitic anhydride increases expression ISO Ccr5 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CCR5 mRNA CTD PMID:16141432 Ccr5 Rat triphenyl phosphate affects expression ISO CCR5 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of CCR5 mRNA CTD PMID:37042841 Ccr5 Rat troglitazone increases expression ISO Ccr5 (Mus musculus) 6480464 troglitazone results in increased expression of CCR5 mRNA CTD PMID:28973697 Ccr5 Rat vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of CCR5 mRNA CTD PMID:23034163 Ccr5 Rat wortmannin multiple interactions ISO Ccr5 (Mus musculus) 6480464 wortmannin inhibits the reaction [[CCL5 protein binds to and results in increased activity of CCR5 protein] which results in increased abundance of Nitric Oxide] CTD PMID:19016906 Ccr5 Rat zidovudine multiple interactions ISO CCR5 (Homo sapiens) 6480464 [Zidovudine co-treated with IFNA1 protein] results in increased expression of CCR5 mRNA CTD PMID:20370541
Imported Annotations - KEGG (archival)
Imported Annotations - PID (archival)
(S)-nicotine (ISO) 1,3-benzothiazole-2-thiol (ISO) 1-chloro-2,4-dinitrobenzene (ISO) 17alpha-ethynylestradiol (EXP,ISO) 17beta-estradiol (EXP) 17beta-estradiol 3-benzoate (EXP) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4,6-trinitrobenzenesulfonic acid (ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 2-naphthylamine (ISO) 3-chlorophenol (ISO) 4,4'-sulfonyldiphenol (ISO) 4-amino-2,6-dinitrotoluene (EXP) 4-hydroxyphenyl retinamide (ISO) acetamide (EXP) aflatoxin B1 (EXP,ISO) ammonium chloride (EXP) amphetamine (EXP) Ancriviroc (ISO) antirheumatic drug (ISO) arsane (ISO) arsenic atom (ISO) Azoxymethane (ISO) Bardoxolone methyl (ISO) benzalkonium chloride (ISO) benzene (ISO) benzo[a]pyrene (ISO) bis(2-chloroethyl) sulfide (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP) bisphenol F (ISO) bleomycin A2 (ISO) buta-1,3-diene (ISO) cadmium atom (ISO) cadmium dichloride (ISO) cannabidiol (ISO) carbon nanotube (ISO) celecoxib (ISO) CGP 52608 (ISO) chloroprene (ISO) Cirsimarin (ISO) cisplatin (ISO) clofibrate (ISO) cocaine (ISO) crocidolite asbestos (ISO) Cuprizon (EXP) cyclophosphamide (ISO) cyclosporin A (ISO) cyproterone acetate (ISO) D-penicillamine (EXP) dextran sulfate (ISO) Dibutyl phosphate (ISO) diclofenac (ISO) Didecyldimethylammonium (ISO) dioxygen (ISO) disulfiram (ISO) diuron (ISO) enniatin (ISO) ethyl methanesulfonate (ISO) eugenol (ISO) formaldehyde (ISO) graphene oxide (ISO) indole-3-methanol (ISO) isopentenyl diphosphate (ISO) ketamine (EXP) lipopolysaccharide (ISO) maraviroc (ISO) mechlorethamine (EXP) mercury dichloride (EXP) methamphetamine (EXP) methyl methanesulfonate (ISO) mevalonic acid (ISO) microcystin-LR (ISO) mycotoxin (ISO) nickel atom (ISO) nicotine (ISO) nitric oxide (ISO) oxaliplatin (EXP) paracetamol (ISO) pentachlorophenol (ISO) phenobarbital (ISO) pirinixic acid (ISO) proanthocyanidin (ISO) prostaglandin E2 (ISO) protein kinase inhibitor (ISO) reactive oxygen species (ISO) resveratrol (ISO) SCH 23390 (EXP) sevoflurane (ISO) silicon dioxide (ISO) simvastatin (EXP,ISO) sodium arsenite (ISO) sodium dodecyl sulfate (ISO) Soman (EXP) staurosporine (EXP) testosterone (EXP) tetrachloromethane (ISO) titanium dioxide (ISO) TMC-120A (ISO) topotecan (EXP) tremolite asbestos (ISO) trichostatin A (ISO) trimellitic anhydride (ISO) triphenyl phosphate (ISO) troglitazone (ISO) vinclozolin (EXP) wortmannin (ISO) zidovudine (ISO)
1.
CCR5 Polymorphism as a Protective Factor for Hepatocellular Carcinoma in Hepatitis B Virus-Infected Iranian Patients
Abdolmohammadi R, etal., Asian Pac J Cancer Prev. 2016 Oct 1;17(10):4643-4646.
2.
Polymorphisms of chemokine and chemokine receptor genes in idiopathic immune-mediated posterior segment uveitis.
Ahad MA, etal., Mol Vis. 2007 Mar 23;13:388-96.
3.
Effects of the CCR5-Delta32 mutation on antiviral treatment in chronic hepatitis C.
Ahlenstiel G, etal., J Hepatol. 2003 Aug;39(2):245-52.
4.
Association of genetic variations in CCR5 and its ligand, RANTES with clearance of hepatitis B virus in Korea.
Ahn SH, etal., J Med Virol. 2006 Dec;78(12):1564-71. doi: 10.1002/jmv.20739.
5.
Linkage and haplotype analysis for chemokine receptors clustered on chromosome 3p21.3 and transmitted in family pedigrees with asthma and atopy.
Al-Abdulhadi SA and Al-Rabia MW, Ann Saudi Med. 2010 Mar-Apr;30(2):115-22.
6.
Temporal course of changes in gene expression suggests a cytokine-related mechanism for long-term hippocampal alteration after controlled cortical impact.
Almeida-Suhett CP, etal., J Neurotrauma. 2014 Apr 1;31(7):683-90. doi: 10.1089/neu.2013.3029. Epub 2014 Mar 3.
7.
Sustained inhibition of corneal neovascularization by genetic ablation of CCR5.
Ambati BK, etal., Invest Ophthalmol Vis Sci 2003 Feb;44(2):590-3.
8.
M- and T-tropic HIVs promote apoptosis in rat neurons.
Bachis A, etal., J Neuroimmune Pharmacol. 2009 Mar;4(1):150-60. Epub 2008 Nov 26.
9.
Host inflammatory response and development of complications of Chlamydia trachomatis genital infection in CCR5-deficient mice and subfertile women with the CCR5delta32 gene deletion.
Barr EL, etal., J Microbiol Immunol Infect. 2005 Aug;38(4):244-54.
10.
CCR 4 and CCR 5 expression in conjunctival specimens as differential markers of T(H)1/ T(H)2 in ocular surface disorders.
Baudouin C, etal., J Allergy Clin Immunol. 2005 Sep;116(3):614-9.
11.
Delayed functional expression of neuronal chemokine receptors following focal nerve demyelination in the rat: a mechanism for the development of chronic sensitization of peripheral nociceptors.
Bhangoo S, etal., Mol Pain. 2007 Dec 12;3:38.
12.
Chronic insulin treatment of diabetes does not fully normalize alterations in the retinal transcriptome.
Bixler GV, etal., BMC Med Genomics. 2011 May 15;4:40. doi: 10.1186/1755-8794-4-40.
13.
Influence of insulin therapy on expression of chemokine receptor CCR5 and selected inflammatory markers in patients with type 2 diabetes mellitus.
Bogdanski P, etal., Int J Clin Pharmacol Ther. 2007 Oct;45(10):563-7.
14.
T cell polarization identifies distinct clinical phenotypes in scleroderma lung disease.
Boin F, etal., Arthritis Rheum. 2008 Apr;58(4):1165-74.
15.
Chemokine and chemokine receptor expression analysis in target organs of acute graft-versus-host disease.
Bouazzaoui A, etal., Genes Immun. 2009 Dec;10(8):687-701. Epub 2009 Jul 2.
16.
Cigarette smoke-induced pulmonary inflammation, but not airway remodelling, is attenuated in chemokine receptor 5-deficient mice.
Bracke KR, etal., Clin Exp Allergy. 2007 Oct;37(10):1467-79.
17.
Analysis of the CC chemokine receptor 5 delta32 polymorphism in a Brazilian population with cutaneous leishmaniasis.
Brajao de Oliveira K, etal., J Cutan Pathol. 2007 Jan;34(1):27-32.
18.
Ccr5 but not Ccr1 deficiency reduces development of diet-induced atherosclerosis in mice.
Braunersreuther V, etal., Arterioscler Thromb Vasc Biol. 2007 Feb;27(2):373-9. Epub 2006 Nov 30.
19.
Polymorphisms in chemokine receptor genes and susceptibility to Kawasaki disease.
Breunis WB, etal., Clin Exp Immunol. 2007 Oct;150(1):83-90. Epub 2007 Aug 2.
20.
Chemotactic mediators of Th1 T-cell trafficking in smokers and COPD patients.
Brozyna S, etal., COPD. 2009 Feb;6(1):4-16.
21.
Possible contribution of chemokine receptor CCR2 and CCR5 polymorphisms in the pathogenesis of chronic spontaneous autoreactive urticaria.
Brzoza Z, etal., Allergol Immunopathol (Madr). 2013 May 30. pii: S0301-0546(13)00103-1. doi: 10.1016/j.aller.2013.02.003.
22.
Genetic variations in the receptor-ligand pair CCR5 and CCL3L1 are important determinants of susceptibility to Kawasaki disease.
Burns JC, etal., J Infect Dis. 2005 Jul 15;192(2):344-9. Epub 2005 Jun 8.
23.
Increased macrophage inflammatory protein-1alpha and macrophage inflammatory protein-1beta levels in bronchoalveolar lavage fluid of patients affected by different stages of pulmonary sarcoidosis.
Capelli A, etal., Am J Respir Crit Care Med. 2002 Jan 15;165(2):236-41.
24.
CCR5 expression and CC chemokine levels in idiopathic pulmonary fibrosis.
Capelli A, etal., Eur Respir J. 2005 Apr;25(4):701-7.
25.
Abnormal immune response of CCR5-deficient mice to ocular infection with herpes simplex virus type 1.
Carr DJ, etal., J Gen Virol. 2006 Mar;87(Pt 3):489-99.
26.
Cellular immune responses to severe acute respiratory syndrome coronavirus (SARS-CoV) infection in senescent BALB/c mice: CD4+ T cells are important in control of SARS-CoV infection.
Chen J, etal., J Virol. 2010 Feb;84(3):1289-301. Epub 2009 Nov 11.
27.
CCR5 knockout mice with C57BL6 background are resistant to acetaminophen-mediated hepatotoxicity due to decreased macrophages migration into the liver.
Choi DY, etal., Arch Toxicol. 2015 Feb;89(2):211-20. doi: 10.1007/s00204-014-1253-3. Epub 2014 Apr 27.
28.
Anti-inflammatory effect of low intensity ultrasound (LIUS) on complete Freund's adjuvant-induced arthritis synovium.
Chung JI, etal., Osteoarthritis Cartilage. 2012 Jan 24.
29.
Microglial expression of chemokine receptor CCR5 during rat forebrain development and after perinatal hypoxia-ischemia.
Cowell RM, etal., J Neuroimmunol. 2006 Apr;173(1-2):155-65. Epub 2006 Mar 3.
30.
Culture and differentiation of preadipocytes in two-dimensional and three-dimensional in vitro systems.
Daya S, etal., Differentiation. 2007 Jun;75(5):360-70. Epub 2007 Feb 5.
31.
MCP-1, CCR2 and CCR5 polymorphisms in Tunisian patients with atopic asthma.
Dhaouadi T, etal., Iran J Allergy Asthma Immunol. 2013 Mar;12(1):29-36. doi: 012.01/ijaai.2936.
32.
Temporal expression and cellular origin of CC chemokine receptors CCR1, CCR2 and CCR5 in the central nervous system: insight into mechanisms of MOG-induced EAE.
Eltayeb S, etal., J Neuroinflammation. 2007 May 7;4:14.
33.
CXCR3-deficiency protects influenza-infected CCR5-deficient mice from mortality.
Fadel SA, etal., Eur J Immunol. 2008 Dec;38(12):3376-87.
34.
The chemokine receptor CCR5 deletion mutation is associated with MS in HLA-DR4-positive Russians.
Favorova OO, etal., Neurology 2002 Nov 26;59(10):1652-5.
35.
Female-specific association of C-C chemokine receptor 5 gene polymorphisms with Lofgren's syndrome.
Fischer A, etal., J Mol Med. 2008 May;86(5):553-61. Epub 2008 Mar 1.
36.
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.
Gaudet P, etal., Brief Bioinform. 2011 Sep;12(5):449-62. doi: 10.1093/bib/bbr042. Epub 2011 Aug 27.
37.
Reduced macrophage infiltration and demyelination in mice lacking the chemokine receptor CCR5 following infection with a neurotropic coronavirus.
Glass WG, etal., Virology. 2001 Sep 15;288(1):8-17. doi: 10.1006/viro.2001.1050.
38.
Controls for lung dendritic cell maturation and migration during respiratory viral infection.
Grayson MH, etal., J Immunol. 2007 Aug 1;179(3):1438-48.
39.
Caffeic acid phenethyl ester modifies the Th1/Th2 balance in ileal mucosa after gamma-irradiation in the rat by modulating the cytokine pattern.
Gremy O, etal., World J Gastroenterol. 2006 Aug 21;12(31):4996-5004.
40.
An immune basis for lung parenchymal destruction in chronic obstructive pulmonary disease and emphysema.
Grumelli S, etal., PLoS Med. 2004 Oct;1(1):e8. Epub 2004 Oct 19.
41.
Expression of cell adhesion molecules, chemokines and chemokine receptors involved in leukocyte traffic in rats undergoing autoimmune orchitis.
Guazzone VA, etal., Reproduction. 2012 May;143(5):651-62. Epub 2012 Feb 20.
42.
Chemokine receptor CCR5 expression in conjunctival epithelium of patients with dry eye syndrome.
Gulati A, etal., Arch Ophthalmol. 2006 May;124(5):710-6.
43.
Chemokine receptor expression in rat adjuvant-induced arthritis.
Haas CS, etal., Arthritis Rheum. 2005 Dec;52(12):3718-30.
44.
Study of the HIV-1 receptors CD4, CXCR4, CCR5 and CCR3 in the human and rat testis.
Habasque C, etal., Mol Hum Reprod 2002 May;8(5):419-25.
45.
Short communication: Influence of active tuberculosis on chemokine and chemokine receptor expression in HIV-infected persons.
Hanna LE, etal., AIDS Res Hum Retroviruses. 2005 Dec;21(12):997-1002.
46.
Gene expression profiling of skin and draining lymph nodes of rats affected with cutaneous contact hypersensitivity.
Hartmann B, etal., Inflamm Res. 2006 Aug;55(8):322-34.
47.
Donor T-cell production of RANTES significantly contributes to the development of idiopathic pneumonia syndrome after allogeneic stem cell transplantation.
Hildebrandt GC, etal., Blood. 2005 Mar 15;105(6):2249-57. Epub 2004 Nov 16.
48.
Abnormal expression of chemokine receptors in Behcet's disease: relationship to intracellular Th1/Th2 cytokines and to clinical manifestations.
Houman H, etal., J Autoimmun. 2004 Nov;23(3):267-73.
49.
Increasing CCL5/CCR5 on CD4+ T cells in peripheral blood of oral lichen planus.
Hu JY, etal., Cytokine. 2013 Apr;62(1):141-5. doi: 10.1016/j.cyto.2013.01.020. Epub 2013 Mar 9.
50.
A CCL5 Haplotype Is Associated with Low Seropositivity Rate of HCV Infection in People Who Inject Drugs.
Huik K, etal., PLoS One. 2016 Jun 15;11(6):e0156850. doi: 10.1371/journal.pone.0156850. eCollection 2016.
51.
Variants of the chemokine receptor CCR5 are associated with severe bronchiolitis caused by respiratory syncytial virus.
Hull J, etal., J Infect Dis. 2003 Sep 15;188(6):904-7. Epub 2003 Sep 9.
52.
Expression of chemokine receptors CXCR4, CCR2, CCR5 and CX3CR1 in neural progenitor cells isolated from the subventricular zone of the adult rat brain.
Ji JF, etal., Neurosci Lett. 2004 Jan 30;355(3):236-40.
53.
Increased expression of RANTES, CCR3 and CCR5 in the lesional skin of patients with atopic eczema.
Kato Y, etal., Int Arch Allergy Immunol. 2006;139(3):245-57. Epub 2006 Jan 30.
54.
Chemokine receptor 5 big up tri, open32 allele in patients with severe pandemic (H1N1) 2009.
Keynan Y, etal., Emerg Infect Dis. 2010 Oct;16(10):1621-2.
55.
Induction of RANTES and CCR5 through NF-kappaB activation via MAPK pathway in aged rat gingival tissues.
Kim HK, etal., Biotechnol Lett. 2006 Jan;28(1):17-23.
56.
The chemokine receptor CCR5 plays a key role in the early memory CD8+ T cell response to respiratory virus infections.
Kohlmeier JE, etal., Immunity. 2008 Jul 18;29(1):101-13.
57.
Pathogenesis of herpetic stromal keratitis in CCR5- and/or CXCR3-deficient mice.
Komatsu K, etal., Curr Eye Res. 2008 Sep;33(9):736-49. doi: 10.1080/02713680802344716.
58.
Decreased pain responses of C-C chemokine receptor 5 knockout mice to chemical or inflammatory stimuli.
Lee YK, etal., Neuropharmacology. 2013 Apr;67:57-65. doi: 10.1016/j.neuropharm.2012.10.030. Epub 2012 Nov 9.
59.
Effects of neferine on CCL5 and CCR5 expression in SCG of type 2 diabetic rats.
Li G, etal., Brain Res Bull. 2013 Jan;90:79-87. doi: 10.1016/j.brainresbull.2012.10.002. Epub 2012 Oct 9.
60.
mRNA expression of chemokine receptors on peripheral blood mononuclear cells and correlation with clinical features in systemic lupus erythematosus patients.
Li YM, etal., Chin Med Sci J. 2010 Sep;25(3):162-8.
61.
Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis.
Lindner E, etal., BMC Med Genet. 2007 Jun 12;8:33.
62.
[Imbalanced T cell-specific transcription factors T-bet and GATA-3 contributes to type 2 T helper cell polarization in asthmatic patients].
Liu CT, etal., Zhonghua Jie He He Hu Xi Za Zhi. 2004 Jun;27(6):398-402.
63.
Immunosuppression with a combination of triptolide and cyclosporin A in rat vascularized groin flap allotransplantation.
Liu F, etal., Plast Reconstr Surg. 2013 Mar;131(3):343e-50e. doi: 10.1097/PRS.0b013e31827c6daa.
64.
Maraviroc attenuates trauma-hemorrhage-induced hepatic injury through PPAR gamma-dependent pathway in rats.
Liu FC, etal., PLoS One. 2013 Oct 18;8(10):e78861. doi: 10.1371/journal.pone.0078861. eCollection 2013.
65.
Regulation of CCL5 expression in smooth muscle cells following arterial injury.
Liu H, etal., PLoS One. 2012;7(1):e30873. doi: 10.1371/journal.pone.0030873. Epub 2012 Jan 23.
66.
Reduced expression of Th1-associated chemokine receptors on peripheral blood lymphocytes at diagnosis of type 1 diabetes.
Lohmann T, etal., Diabetes. 2002 Aug;51(8):2474-80.
67.
Role of CCR5 and its ligands in the control of vascular inflammation and leukocyte recruitment required for acute excitotoxic seizure induction and neural damage.
Louboutin JP, etal., FASEB J. 2010 Oct 12.
68.
Role of CCR5 in IFN-gamma-induced and cigarette smoke-induced emphysema.
Ma B, etal., J Clin Invest. 2005 Dec;115(12):3460-72. Epub 2005 Nov 10.
69.
CCR1 and CCR5 chemokine receptors are involved in fever induced by LPS (E. coli) and RANTES in rats.
Machado RR, etal., Brain Res. 2007 Jun 9;.
70.
The CCR5 delta 32 polymorphism (rs333) is not associated with Sjogren's syndrome or Type 1 Diabetes in Colombians.
Maier-Moore JS, etal., Clin Immunol. 2013 Aug;148(2):206-8. doi: 10.1016/j.clim.2013.05.010. Epub 2013 May 24.
71.
Toll like receptor 2 and CC chemokine receptor 5 cluster in the lipid raft enhances the susceptibility of Leishmania donovani infection in macrophages.
Majumdar SB, etal., Indian J Exp Biol. 2014 Jan;52(1):17-29.
72.
Association of CCR2-CCR5 haplotypes and CCL3L1 copy number with Kawasaki Disease, coronary artery lesions, and IVIG responses in Japanese children.
Mamtani M, etal., PLoS One. 2010 Jul 7;5(7):e11458. doi: 10.1371/journal.pone.0011458.
73.
Crucial role of CCL3/MIP-1alpha in the recurrence of autoimmune anterior uveitis induced with myelin basic protein in Lewis rats.
Manczak M, etal., J Autoimmun. 2002 Jun;18(4):259-70.
74.
CCR5 expression influences the progression of human breast cancer in a p53-dependent manner.
Manes S, etal., J Exp Med. 2003 Nov 3;198(9):1381-9.
75.
Angiotensin II-induced mononuclear leukocyte interactions with arteriolar and venular endothelium are mediated by the release of different CC chemokines.
Mateo T, etal., J Immunol. 2006 May 1;176(9):5577-86.
76.
Characterization and identification of subpopulations of mononuclear preosteoclasts induced by TNF-α in combination with TGF-β in rats.
Matsubara R, etal., PLoS One. 2012;7(10):e47930. doi: 10.1371/journal.pone.0047930. Epub 2012 Oct 24.
77.
Chemokine (C-C motif) Receptor 5 Is an Important Pathological Regulator in the Development and Maintenance of Neuropathic Pain.
Matsushita K, etal., Anesthesiology. 2014 Feb 28.
78.
Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy.
Melli G, etal., Brain. 2006 May;129(Pt 5):1330-8. Epub 2006 Mar 14.
79.
Immunoregulatory role of nitric oxide in Kilham rat virus-induced autoimmune diabetes in DR-BB rats.
Mendez II, etal., J Immunol. 2004 Jul 15;173(2):1327-35.
80.
CCR5 and CCR2 gene polymorphisms in hypertensive patients.
Mettimano M, etal., Br J Biomed Sci. 2003;60(1):19-21.
81.
Rat ISS GO annotations from MGI mouse gene data--August 2006
MGD data from the GO Consortium
82.
Analysis of chemokines and chemokine receptor expression in ovarian cancer ascites.
Milliken D, etal., Clin Cancer Res. 2002 Apr;8(4):1108-14.
83.
Association of chemokine receptor 5 (CCR5) delta32 mutation with Behcet's disease is dependent on gender in Iranian patients.
Mojtahedi Z, etal., Clin Exp Rheumatol. 2006 Sep-Oct;24(5 Suppl 42):S91-4.
84.
CCR5-dependent regulatory T cell migration mediates fungal survival and severe immunosuppression.
Moreira AP, etal., J Immunol. 2008 Mar 1;180(5):3049-56.
85.
CCR5 deficiency exacerbates T-cell-mediated hepatitis in mice.
Moreno C, etal., Hepatology. 2005 Oct;42(4):854-62. doi: 10.1002/hep.20865.
86.
Chemokine-receptor upregulation and disease severity in respiratory syncytial virus infection.
Morrison PT, etal., Clin Immunol. 2008 Jul;128(1):85-93. Epub 2008 Apr 25.
87.
RANTES promoter genotype is associated with diabetic nephropathy in type 2 diabetic subjects.
Nakajima K, etal., Diabetes Care. 2003 Mar;26(3):892-8.
88.
Regulation of CC chemokine receptor 5 in hepatitis G virus infection.
Nattermann J, etal., AIDS. 2003 Jul 4;17(10):1457-62. doi: 10.1097/01.aids.0000076271.76134.58.
89.
Electronic Transfer of LocusLink and RefSeq Data
NCBI rat LocusLink and RefSeq merged data July 26, 2002
90.
CCR5 and CCR3 expression on T CD3+ lymphocytes from HIV/Leishmania co-infected subjects.
Nigro L, etal., Med Microbiol Immunol. 2007 Dec;196(4):253-5. Epub 2007 Apr 25.
91.
Intrauterine growth restriction alters hippocampal expression and chromatin structure of Cyp19a1 variants.
O'Grady SP, etal., Syst Biol Reprod Med. 2010 Aug;56(4):292-302.
92.
Didecyldimethylammonium chloride induces pulmonary inflammation and fibrosis in mice.
Ohnuma A, etal., Exp Toxicol Pathol. 2009 Sep 15.
93.
OMIM Disease Annotation Pipeline
OMIM Disease Annotation Pipeline
94.
Attenuation of rodent neuropathic pain by an orally active peptide, RAP-103, which potently blocks CCR2- and CCR5-mediated monocyte chemotaxis and inflammation.
Padi SS, etal., Pain. 2012 Jan;153(1):95-106. doi: 10.1016/j.pain.2011.09.022. Epub 2011 Oct 26.
95.
Polymorphisms in the CC-chemokine receptor-2 (CCR2) and -5 (CCR5) genes and risk of coronary heart disease among US women.
Pai JK, etal., Atherosclerosis. 2006 May;186(1):132-9. Epub 2005 Aug 1.
96.
C-C chemokine receptor type 5 deficiency exacerbates alcoholic fatty liver disease through pro-inflammatory cytokines and chemokines-induced hepatic inflammation.
Park JH, etal., J Gastroenterol Hepatol. 2017 Jun;32(6):1258-1264. doi: 10.1111/jgh.13657.
97.
Chemokines released from astrocytes promote chemokine receptor 5-mediated neuronal cell differentiation.
Park MH, etal., Exp Cell Res. 2009 Oct 1;315(16):2715-26. Epub 2009 Jun 24.
98.
Elevated expression of CCR5 by myeloid (CD11c+) blood dendritic cells in multiple sclerosis and acute optic neuritis.
Pashenkov M, etal., Clin Exp Immunol. 2002 Mar;127(3):519-26.
99.
CC chemokine receptor 5 and interleukin-1 receptor antagonist gene polymorphisms in patients with primary Sjogren's syndrome.
Petrek M, etal., Clin Exp Rheumatol. 2002 Sep-Oct;20(5):701-3.
100.
CC chemokine receptor 5 (CCR5) deletion polymorphism does not protect Czech males against early myocardial infarction.
Petrkova J, etal., J Intern Med. 2005 Jun;257(6):564-6.
101.
KEGG Annotation Import Pipeline
Pipeline to import KEGG annotations from KEGG into RGD
102.
PID Annotation Import Pipeline
Pipeline to import Pathway Interaction Database annotations from NCI into RGD
103.
Differential upregulation of chemokine receptors on CD56 NK cells and their transmigration to the site of infection in tuberculous pleurisy.
Pokkali S, etal., FEMS Immunol Med Microbiol. 2009 Apr;55(3):352-60. Epub 2009 Jan 12.
104.
Analysis of ligand-stimulated CC chemokine receptor 5 (CCR5) phosphorylation in intact cells using phosphosite-specific antibodies.
Pollok-Kopp B, etal., J Biol Chem 2003 Jan 24;278(4):2190-8.
105.
Role of bone marrow-derived CC-chemokine receptor 5 in the development of atherosclerosis of low-density lipoprotein receptor knockout mice.
Potteaux S, etal., Arterioscler Thromb Vasc Biol. 2006 Aug;26(8):1858-63. Epub 2006 Jun 8.
106.
Negative association between the chemokine receptor CCR5-Delta32 polymorphism and rheumatoid arthritis: a meta-analysis.
Prahalad S Genes Immun. 2006 Apr;7(3):264-8.
107.
Association of two functional polymorphisms in the CCR5 gene with juvenile rheumatoid arthritis.
Prahalad S, etal., Genes Immun. 2006 Sep;7(6):468-75. Epub 2006 Jun 15.
108.
Association of TGFbeta1, TNFalpha, CCR2 and CCR5 gene polymorphisms in type-2 diabetes and renal insufficiency among Asian Indians.
Prasad P, etal., BMC Med Genet. 2007 Apr 12;8:20.
109.
GOA pipeline
RGD automated data pipeline
110.
ClinVar Automated Import and Annotation Pipeline
RGD automated import pipeline for ClinVar variants, variant-to-disease annotations and gene-to-disease annotations
111.
Data Import for Chemical-Gene Interactions
RGD automated import pipeline for gene-chemical interactions
112.
Effect of the chemokine receptor CCR5 in the development of American cutaneous leishmaniasis in a Southern Brazilian population.
Ribas AD, etal., Mol Med Rep. 2013 Jul;8(1):189-94. doi: 10.3892/mmr.2013.1452. Epub 2013 Apr 30.
113.
HIV-1 viral envelope glycoprotein gp120 triggers an inflammatory response in cultured rat astrocytes and regulates the functional expression of P-glycoprotein.
Ronaldson PT and Bendayan R, Mol Pharmacol. 2006 Sep;70(3):1087-98. Epub 2006 Jun 21.
114.
Chemokine receptor 5 antagonist D-Ala-peptide T-amide reduces microglia and astrocyte activation within the hippocampus in a neuroinflammatory rat model of Alzheimer's disease.
Rosi S, etal., Neuroscience. 2005;134(2):671-6.
115.
CC chemokine receptor 5 gene polymorphisms in beryllium disease.
Sato H, etal., Eur Respir J. 2010 Aug;36(2):331-8. Epub 2010 Jan 14.
116.
CARD15/NOD2 polymorphisms are associated with severe pulmonary sarcoidosis.
Sato H, etal., Eur Respir J. 2010 Feb;35(2):324-30. Epub 2009 Aug 13.
117.
Defects in the generation of IFN-gamma are overcome to control infection with Leishmania donovani in CC chemokine receptor (CCR) 5-, macrophage inflammatory protein-1 alpha-, or CCR2-deficient mice.
Sato N, etal., J Immunol. 1999 Nov 15;163(10):5519-25.
118.
Post-reperfusion changes of monocyte function in coronary blood after extracorporeal circulation.
Sbrana S, etal., Cytometry B Clin Cytom. 2005 May;65(1):14-21.
119.
Role of FTY720 on M1 and M2 macrophages, lymphocytes, and chemokines in 5/6 nephrectomized rats.
Schaier M, etal., Am J Physiol Renal Physiol. 2009 Sep;297(3):F769-80. Epub 2009 Jun 17.
120.
CCR1 and CCR5 promote hepatic fibrosis in mice.
Seki E, etal., J Clin Invest. 2009 Jul;119(7):1858-70.
121.
CD11b+ bone marrow-derived monocytes are the major leukocyte subset responsible for retinal capillary leukostasis in experimental diabetes in mouse and express high levels of CCR5 in the circulation.
Serra AM, etal., Am J Pathol. 2012 Aug;181(2):719-27. doi: 10.1016/j.ajpath.2012.04.009. Epub 2012 Jun 4.
122.
Chemokine receptor expression and in vivo signaling pathways in the joints of rats with adjuvant-induced arthritis.
Shahrara S, etal., Arthritis Rheum. 2003 Dec;48(12):3568-83.
123.
Effect of genital ulcer disease on HIV-1 coreceptor expression in the female genital tract.
Sheffield JS, etal., J Infect Dis. 2007 Nov 15;196(10):1509-16. Epub 2007 Oct 31.
124.
Role of CC-chemokine receptor 5 on myocardial ischemia-reperfusion injury in rats.
Shen B, etal., Mol Cell Biochem. 2013 Jun;378(1-2):137-44. doi: 10.1007/s11010-013-1604-z. Epub 2013 Mar 3.
125.
CD8 chemokine receptors in chronic obstructive pulmonary disease.
Smyth LJ, etal., Clin Exp Immunol. 2008 Oct;154(1):56-63. Epub 2008 Aug 22.
126.
Chemokine ligand (CCL)-3 promotes an integrated febrile response when injected within pre-optic area (POA) of rats and induces calcium signaling in cells of POA microcultures but not TNF-alpha or IL-6 synthesis.
Soares DM, etal., Brain Behav Immun. 2013 Nov;34:120-9. doi: 10.1016/j.bbi.2013.08.005. Epub 2013 Aug 30.
127.
Psoriasis patients exhibit impairment of the high potency CCR5(+) T regulatory cell subset.
Soler DC, etal., Clin Immunol. 2013 Oct;149(1):111-8. doi: 10.1016/j.clim.2013.06.007. Epub 2013 Jul 6.
128.
Cloning of rat HIV-1-chemokine coreceptor CKR5 from microglia and upregulation of its mRNA in ischemic and endotoxinemic rat brain.
Spleiss O, etal., J Neurosci Res 1998 Jul 1;53(1):16-28.
129.
CCR5 Delta32 polymorphism: associated with gallbladder cancer susceptibility.
Srivastava A, etal., Scand J Immunol. 2008 May;67(5):516-22.
130.
Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.
Strausberg RL, etal., Proc Natl Acad Sci U S A. 2002 Dec 24;99(26):16899-903. Epub 2002 Dec 11.
131.
RANTES/CCL5-induced pro-angiogenic effects depend on CCR1, CCR5 and glycosaminoglycans.
Suffee N, etal., Angiogenesis. 2012 Dec;15(4):727-44. doi: 10.1007/s10456-012-9285-x. Epub 2012 Jun 30.
132.
Cytokine and chemokine transcription profile during Mycoplasma pulmonis infection in susceptible and resistant strains of mice: macrophage inflammatory protein 1beta (CCL4) and monocyte chemoattractant protein 2 (CCL8) and accumulation of CCR5+ Th cells.
Sun X, etal., Infect Immun. 2006 Oct;74(10):5943-54.
133.
A small-molecule compound targeting CCR5 and CXCR3 prevents airway hyperresponsiveness and inflammation.
Suzaki Y, etal., Eur Respir J. 2008 Apr;31(4):783-9. Epub 2007 Dec 19.
134.
Disruption of CCR5-dependent homing of regulatory T cells inhibits tumor growth in a murine model of pancreatic cancer.
Tan MC, etal., J Immunol. 2009 Feb 1;182(3):1746-55.
135.
Differential sensitivities of pyrogenic chemokine fevers to CC chemokine receptor 5 antibodies.
Tavares E and Minano FJ, Fundam Clin Pharmacol. 2004 Apr;18(2):163-9.
136.
Multiple sclerosis and optic neuritis: CCR5 and CXCR3 expressing T cells are augmented in blood and cerebrospinal fluid.
Teleshova N, etal., J Neurol. 2002 Jun;249(6):723-9.
137.
RANTES has a potential to play a neuroprotective role in an autocrine/paracrine manner after ischemic stroke.
Tokami H, etal., Brain Res. 2013 Jun 23;1517:122-32. doi: 10.1016/j.brainres.2013.04.022. Epub 2013 Apr 18.
138.
CCR5 polymorphism and plague resistance in natural populations of the black rat in Madagascar.
Tollenaere C, etal., Infect Genet Evol. 2008 Dec;8(6):891-7. Epub 2008 Jul 25.
139.
Th1- and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis.
Trinh L, etal., Mol Vis. 2008;14:2428-34. Epub 2008 Dec 19.
140.
CCR5 Delta 32 mutation, Mycoplasma pneumoniae infection, and asthma.
Ungvari I, etal., J Allergy Clin Immunol. 2007 Jun;119(6):1545-7. Epub 2007 Apr 18.
141.
Localization and expression of CCR3 and CCR5 by interleukin-1 beta in the RIN-5AH insulin-producing model system: a protective mechanism involving down-regulation of chemokine receptors.
Vassiliadis S, etal., JOP 2002 May;3(3):66-75.
142.
CCR5 antagonist blocks metastasis of basal breast cancer cells.
Velasco-Velazquez M, etal., Cancer Res. 2012 Aug 1;72(15):3839-50. doi: 10.1158/0008-5472.CAN-11-3917. Epub 2012 May 25.
143.
Immune regulation and vascular inflammation in genetic hypertension.
Viel EC, etal., Am J Physiol Heart Circ Physiol. 2010 Mar;298(3):H938-44. Epub 2009 Dec 31.
144.
Absence of CCR5 increases neutrophil recruitment in severe herpetic encephalitis.
Vilela MC, etal., BMC Neurosci. 2013 Feb 7;14:19. doi: 10.1186/1471-2202-14-19.
145.
Multistrain genetic comparisons reveal CCR5 as a receptor involved in airway hyperresponsiveness.
Walker JK, etal., Am J Respir Cell Mol Biol. 2006 Jun;34(6):711-8. Epub 2006 Feb 10.
146.
CC chemokine receptor 5 delta32 polymorphism in two independent cohorts of hepatitis C virus infected patients without hemophilia.
Wasmuth HE, etal., J Mol Med (Berl). 2004 Jan;82(1):64-9. doi: 10.1007/s00109-003-0505-0. Epub 2003 Dec 13.
147.
Frequency of the HIV-protective CC chemokine receptor 5-Delta32/Delta32 genotype is increased in hepatitis C.
Woitas RP, etal., Gastroenterology. 2002 Jun;122(7):1721-8.
148.
Cytokine expression after vaginal distention of different durations in virgin Sprague-Dawley rats.
Wood HM, etal., J Urol. 2008 Aug;180(2):753-9. Epub 2008 Jun 13.
149.
Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains.
Xia MQ, etal., Am J Pathol. 1998 Jul;153(1):31-7.
150.
Effects of the NF-kappaB inhibitor pyrrolidine dithiocarbamate on experimentally induced autoimmune anterior uveitis.
Yang CH, etal., Invest Ophthalmol Vis Sci. 2005 Apr;46(4):1339-47.
151.
Analysis of the CC chemokine receptor 5 (CCR5) Delta32 polymorphism in Behcet's disease.
Yang X, etal., Eur J Immunogenet. 2004 Feb;31(1):11-4.
152.
Inhibition of chemokine receptor CCR2 and CCR5 expression contributes to simvastatin-induced attenuation of cardiac allograft vasculopathy.
Yin R, etal., J Heart Lung Transplant. 2007 May;26(5):485-93.
153.
Correlations between polymorphisms in the uridine diphosphate-glucuronosyltransferase 1A and C-C motif chemokine receptor 5 genes and infection with the hepatitis B virus in three ethnic groups in China.
Zhang C, etal., J Int Med Res. 2018 Feb;46(2):739-751. doi: 10.1177/0300060517730174. Epub 2017 Sep 20.
154.
Genetic variations in CC chemokine receptors and hypertension.
Zhang M, etal., Am J Hypertens. 2006 Jan;19(1):67-72.
155.
Complementary DNA microarray analysis of chemokines and their receptors in allergic rhinitis.
Zhang RX, etal., J Investig Allergol Clin Immunol. 2007;17(5):329-36.
156.
Association of chemotactic factor receptor 5 gene with breast cancer.
Zhang Y, etal., Genet Mol Res. 2013 Nov 7;12(4):5289-300. doi: 10.4238/2013.November.7.4.
157.
The significance for chronic rejection of cardiac allograft of regulated upon activation normal T-cell cytokine and its CCR5 receptor.
Zhao H, etal., Transplant Proc. 2013 Mar;45(2):635-8. doi: 10.1016/j.transproceed.2012.03.065.
158.
Relative importance of CCR5 and antineutrophil cytoplasmic antibodies in patients with Wegener's granulomatosis.
Zhou Y, etal., J Rheumatol. 2003 Jul;30(7):1541-7.
159.
Characterization of the expression of macrophage inflammatory protein-1alpha (MIP-1alpha) and C-C chemokine receptor 5 (CCR5) after kainic acid-induced status epilepticus (SE) in juvenile rats.
Zhu XB, etal., Neuropathol Appl Neurobiol. 2012 Oct;38(6):602-16. doi: 10.1111/j.1365-2990.2012.01251.x.
Ccr5 (Rattus norvegicus - Norway rat)
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 8 132,629,097 - 132,660,980 (+) NCBI GRCr8 mRatBN7.2 8 123,752,423 - 123,757,538 (+) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 8 123,752,325 - 123,759,260 (+) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 8 129,343,076 - 129,348,190 (+) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 8 127,542,196 - 127,547,310 (+) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 8 125,360,117 - 125,365,231 (+) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 8 133,192,398 - 133,215,599 (+) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 8 133,197,032 - 133,215,614 (+) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 8 132,362,664 - 132,367,779 (+) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 8 128,907,157 - 128,912,272 (+) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 RGSC_v3.1 8 128,929,594 - 128,932,000 (+) NCBI Celera 8 122,847,673 - 122,852,786 (+) NCBI Celera Cytogenetic Map 8 q32 NCBI
CCR5 (Homo sapiens - human)
Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 3 46,370,142 - 46,376,206 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 3 46,370,946 - 46,376,206 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 3 46,411,633 - 46,417,697 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 3 46,386,637 - 46,392,701 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Celera 3 46,348,960 - 46,355,024 (+) NCBI Celera Cytogenetic Map 3 p21.31 NCBI HuRef 3 46,455,276 - 46,461,340 (+) NCBI HuRef CHM1_1 3 46,361,630 - 46,367,689 (+) NCBI CHM1_1 T2T-CHM13v2.0 3 46,385,976 - 46,392,040 (+) NCBI T2T-CHM13v2.0
Ccr5 (Mus musculus - house mouse)
Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 9 123,921,557 - 123,934,153 (+) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 9 123,921,580 - 123,947,736 (+) Ensembl GRCm39 Ensembl GRCm38 9 124,121,543 - 124,127,183 (+) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 9 124,121,543 - 124,147,699 (+) Ensembl GRCm38 mm10 GRCm38 MGSCv37 9 124,036,282 - 124,041,922 (+) NCBI GRCm37 MGSCv37 mm9 NCBIm37 Celera 9 124,872,533 - 124,878,180 (-) NCBI Celera Cytogenetic Map 9 F4 NCBI cM Map 9 75.05 NCBI
CCR5 (Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 2 46,330,233 - 46,335,608 (+) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 3 46,335,001 - 46,340,376 (+) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 3 46,273,096 - 46,278,471 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 3 47,377,564 - 47,383,625 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 3 47,380,321 - 47,381,379 (+) Ensembl panpan1.1 panPan2
CCR5 (Canis lupus familiaris - dog)
Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 20 42,293,288 - 42,297,952 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 20 42,294,996 - 42,297,952 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 20 42,210,909 - 42,213,866 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 20 42,775,514 - 42,780,183 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 20 42,775,514 - 42,780,191 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 20 42,018,434 - 42,021,393 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 20 42,419,865 - 42,422,824 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 20 42,700,801 - 42,703,760 (-) NCBI UU_Cfam_GSD_1.0
CCR5 (Sus scrofa - pig)
Pig Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl Sscrofa11.1 Ensembl 13 29,383,303 - 29,387,895 (+) Ensembl Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa11.1 13 29,382,383 - 29,387,902 (+) NCBI Sscrofa11.1 Sscrofa11.1 susScr11 Sscrofa11.1 Sscrofa10.2 13 32,546,545 - 32,551,732 (+) NCBI Sscrofa10.2 Sscrofa10.2 susScr3
CCR5 (Chlorocebus sabaeus - green monkey)
.
Predicted Target Of
Count of predictions: 18 Count of miRNA genes: 18 Interacting mature miRNAs: 18 Transcripts: ENSRNOT00000075564 Prediction methods: Miranda, Rnahybrid Result types: miRGate_prediction
738011 Anxrr9 Anxiety related response QTL 9 6.1 exploratory behavior trait (VT:0010471) number of entries into a discrete space in an experimental apparatus (CMO:0000960) 8 93535351 123900184 Rat 1358903 Bp252 Blood pressure QTL 252 7 0.0001 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 93965141 123900184 Rat 738014 Anxrr15 Anxiety related response QTL 15 3.6 0.005 locomotor behavior trait (VT:0001392) amount of experiment time spent in a discrete space in an experimental apparatus (CMO:0000958) 8 95718998 123900184 Rat 2300182 Bmd56 Bone mineral density QTL 56 5.4 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 95718998 123900184 Rat 1554321 Bmd3 Bone mineral density QTL 3 7.9 0.0001 femur mineral mass (VT:0010011) volumetric bone mineral density (CMO:0001553) 8 40952565 123900184 Rat 1358893 Bp263 Blood pressure QTL 263 5.01 arterial blood pressure trait (VT:2000000) mean arterial blood pressure (CMO:0000009) 8 93965141 123900184 Rat
Cmkbr5
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 123,756,008 - 123,756,165 (+) MAPPER mRatBN7.2 Rnor_6.0 8 133,214,070 - 133,214,226 NCBI Rnor6.0 Rnor_5.0 8 132,366,250 - 132,366,406 UniSTS Rnor5.0 RGSC_v3.4 8 128,910,743 - 128,910,899 UniSTS RGSC3.4 Celera 8 122,851,258 - 122,851,414 UniSTS Cytogenetic Map 8 q32 UniSTS
PMC122923P1
Rat Assembly Chr Position (strand) Source JBrowse mRatBN7.2 8 123,755,127 - 123,755,373 (+) MAPPER mRatBN7.2 Rnor_6.0 8 133,213,189 - 133,213,434 NCBI Rnor6.0 Rnor_5.0 8 132,365,369 - 132,365,614 UniSTS Rnor5.0 RGSC_v3.4 8 128,909,862 - 128,910,107 UniSTS RGSC3.4 Celera 8 122,850,377 - 122,850,622 UniSTS Cytogenetic Map 8 q32 UniSTS
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
47
113
91
90
59
25
59
6
216
95
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000075564 ⟹ ENSRNOP00000066146
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source Rnor_6.0 Ensembl 8 133,197,032 - 133,214,257 (+) Ensembl
Ensembl Acc Id:
ENSRNOT00000082774 ⟹ ENSRNOP00000073121
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 8 123,752,325 - 123,759,260 (+) Ensembl Rnor_6.0 Ensembl 8 133,210,473 - 133,215,614 (+) Ensembl
RefSeq Acc Id:
NM_053960 ⟹ NP_446412
RefSeq Status:
VALIDATED
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 132,629,843 - 132,634,958 (+) NCBI mRatBN7.2 8 123,752,423 - 123,757,538 (+) NCBI Rnor_6.0 8 133,210,484 - 133,215,599 (+) NCBI Rnor_5.0 8 132,362,664 - 132,367,779 (+) NCBI RGSC_v3.4 8 128,907,157 - 128,912,272 (+) RGD Celera 8 122,847,673 - 122,852,786 (+) RGD
Sequence:
GATTTGTACTGCTCTCCTAGCAAGAGAAGGTGAGACATCCGTTCCCTCTACAAGAAACTCTGGCTCTTGCAGGATGGATTTTCAAGGGTCGATTCCAACCTATATCTATGACATCGATTATAGTATGT CAGCACCCTGCCAAAAATTCAATGTGAAACAAATTGCAGCCCAGCTCCTGCCCCCACTCTACTCTCTGGTATTCATCTTTGGTTTTGTGGGTAACATGATGGTCTTCCTCATCCTGATAAGCTGCAAA AAGCTGAAGAGCATGACTGATATCTACCTGTTCAACCTGGCCATCTCTGACCTGCTCTTCCTGCTCACACTCCCATTCTGGGCTCACTATGCTGCAAATGAGTGGGTCTTTGGGAATATAATGTGCAA ATTATTCACAGGGATCTATCACATTGGTTATTTTGGTGGAATCTTCTTCATTATCCTCCTGACAATTGATAGGTACTTGGCTATTGTCCATGCTGTGTTTGCTATAAAAGCCAGAACAGTCAACTTTG GGGTAATAACAAGTGTAGTCACTTGGGTGGTGGCTGTGTTTGTCTCTCTCCCAGAAATAATCTTTATGAGATCTCAAAAAGAAGGTTCTCATTATACATGCAGTCCTCATTTTCCACGTATTCAATAT CGTTTCTGGAAGCATTTTCAAACATTAAAGATGGTCATCTTGAGCCTGATCCTACCCCTACTTGTCATGGTCATCTGCTATTCAGGAATCCTCAACACCCTGTTTCGCTGTAGGAATGAGAAGAAGAG GCACAGGGCTGTAAGGCTCATCTTTGCCATCATGATTGTCTACTTTCTCTTCTGGACTCCCTACAACATTGTCCTCCTCCTGACCACCTTCCAGGAATACTTTGGACTGAATAATTGCAGTAGTTCTA ATAGACTAGACCAGGCAATGCAGGTGACAGAGACTCTTGGGATGACACACTGCTGCCTCAACCCTGTCATCTATGCCTTTGTTGGGGAGAAGTTCCGGAATTATCTCTCTGTGTTCTTCCGAAAACAC ATTGTCAAACGCTTCTGCAAACACTGTTCAATTTTCCAGCAAGTCAATCCTGATCGTGTAAGCTCAGTCTATACCCGGTCCACAGGAGAACAGGAAGTTTCTACTGGTTTATGAGCTAGGTTGAGTTT TGTGTATCACTTAGTTTTTTTATGTAGCTTGAGGGTAGAGATGGTTCTTTTAGAAAAGAAATTAATATAGAGGGCCTAAGGTACGTGCATTGTTTTAATATTTATTTGAGATAGATTGGGTCTTTGAA AGCTGAGTAGTTTTATAAACGTGAATGAGAATGTATTGATGAGACAGTAATTTCTGGCTTCATTCCTATTTAACTACAATTATTGCCAAACTCTTCTTTAGCCACAAAAGTTCACTATTAAAAAATAC TGAGCATTGGGATTTTTTTTTTTAGAGCTTGAGTATCTGACCAAAAATAACATCATTTTTTCCCTATATAAAGCAAAATTCAGGCTACTTAAATCAGGTCTTTGTCTTGCCCTGAGAAGAAAGGATGA GACCATGACTAGTTAGGGAATAGATAACCAAGCTATATGAATTGCTTTATAGACTTGTATGATCAGTAAGTGCTCTGTGGCCTGAGAAGGCTGGGAACAAGTCTTTATAAAAAGAGATTTGAACTGGA TCCTTGTTAGTAAATGAGAGGGAAGCCATTCTCTGGGTGGTATGGCTATATGAGTGAAGCAAGGGTAGAGCTGTGACTAGTTGAAGAGGACATGAAGAGAATGGTCAAGGCCGAATCCTAAGGCATCA TATCAGCATTGCTTCTTCAGAGTTATGAGCATGGTGGGGAGCACCTAGACAGGTTTGTACAAAGCTTGTTTCATGGCTAAGAAAGTCTGGCAATGGTGAGCATTGAGGGCTAGTAAGTCAGCAGTAAT AAGGTTAGGATGAAATCATGTCACCTGGGCTAGGCAGAGGAGAATGTTAGAAGAACAAATTACATCATGCAGCATGTAGGTCTCATGTGGGAGGTTTACTGGGAGGAGGAGACAGAAGTAGATTGTTG TGAAGTCAATTCTAGCTGTCCACGGATGTGCTTGATTGCTAACAGGGAAGAACCACTTCTGCACATAAAATATAGAGTCAGCAGAACTTGGGATAAATTGCAGTTAAAGGTGAACAAGAACCCCTAGG CTTAATTAGGTTGGAATAACCATTGAGGAAACAACAAATACAAAGTGAGAATAAAGGAAAGAGCTTGTCCTAGGAAGATGGTCTCATTTTGCAGCCTGAATATAATGTCTCAGGCTGTCATTTTGTTC CTGCATTCAGATGTAAATCCTACCGTACCAGCTTTGATCCTGAAGGGTCACCAGGGGGCTGTGAAATACCTGGATTAAGAATCATGAGCCTGGGGGTTGGGGACTTAGCTCAGTGGTAGAGCGCTTGC CTAGCAAGCGCAAGGCCCTGGGTTCGGTCCCCAGCTCCGAAAAAAAAAAAAAAAAAAAAAAAA
hide sequence
RefSeq Acc Id:
XM_063264783 ⟹ XP_063120853
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 132,629,097 - 132,660,980 (+) NCBI
RefSeq Acc Id:
XM_063264784 ⟹ XP_063120854
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 132,629,097 - 132,660,980 (+) NCBI
RefSeq Acc Id:
XR_010053918
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 132,629,097 - 132,660,980 (+) NCBI
RefSeq Acc Id:
XR_010053919
Type:
NON-CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 8 132,629,097 - 132,660,980 (+) NCBI
RefSeq Acc Id:
NP_446412 ⟸ NM_053960
- UniProtKB:
Q68G28 (UniProtKB/TrEMBL), A6I4D3 (UniProtKB/TrEMBL)
- Sequence:
MDFQGSIPTYIYDIDYSMSAPCQKFNVKQIAAQLLPPLYSLVFIFGFVGNMMVFLILISCKKLKSMTDIYLFNLAISDLLFLLTLPFWAHYAANEWVFGNIMCKLFTGIYHIGYFGGIFFIILLTIDR YLAIVHAVFAIKARTVNFGVITSVVTWVVAVFVSLPEIIFMRSQKEGSHYTCSPHFPRIQYRFWKHFQTLKMVILSLILPLLVMVICYSGILNTLFRCRNEKKRHRAVRLIFAIMIVYFLFWTPYNIV LLLTTFQEYFGLNNCSSSNRLDQAMQVTETLGMTHCCLNPVIYAFVGEKFRNYLSVFFRKHIVKRFCKHCSIFQQVNPDRVSSVYTRSTGEQEVSTGL
hide sequence
Ensembl Acc Id:
ENSRNOP00000073121 ⟸ ENSRNOT00000082774
Ensembl Acc Id:
ENSRNOP00000066146 ⟸ ENSRNOT00000075564
RefSeq Acc Id:
XP_063120853 ⟸ XM_063264783
- Peptide Label:
isoform X1
RefSeq Acc Id:
XP_063120854 ⟸ XM_063264784
- Peptide Label:
isoform X1
RGD ID: 13696416
Promoter ID: EPDNEW_R6941
Type: initiation region
Name: Ccr5_1
Description: chemokine (C-C motif) receptor 5
SO ACC ID: SO:0000170
Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ )
Experiment Methods: Single-end sequencing.
Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 8 133,210,484 - 133,210,544 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2018-03-16
Ccr5
C-C motif chemokine receptor 5
Ccr5
chemokine (C-C motif) receptor 5
Nomenclature updated to reflect human and mouse nomenclature
1299863
APPROVED
2006-03-30
Ccr5
chemokine (C-C motif) receptor 5
chemokine (C-C) receptor 5
Name updated
1299863
APPROVED
2004-09-10
Ccr5
chemokine (C-C) receptor 5
Cmkbr5
Symbol and Name updated
1299863
APPROVED
2002-08-07
Cmkbr5
chemokine (C-C) receptor 5
Symbol and Name status set to provisional
70820
PROVISIONAL
Note Type
Note
Reference
gene_regulation
phosphorylated by GPCR kinase (GRK)- and protein kinase C (PKC) following RANTES/CCL5 binding to receptor
632395
gene_regulation
expression upregulated following bacterial infection
632396
gene_regulation
downregulation of receptor is induced by interleukin-1beta
632389